Free Trial
NASDAQ:CERO

CERo Therapeutics (CERO) Stock Price, News & Analysis

CERo Therapeutics logo
$0.22 -0.03 (-12.09%)
(As of 11/22/2024 ET)

About CERo Therapeutics Stock (NASDAQ:CERO)

Key Stats

Today's Range
$0.21
$0.25
50-Day Range
$0.07
$0.29
52-Week Range
$0.06
$12.80
Volume
9.67 million shs
Average Volume
20.67 million shs
Market Capitalization
$32.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Receive CERO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CERO Stock News Headlines

“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
3 Penny Stocks to Watch Now, 11/19/24
Cero Therapeutics receives FDA clearance of IND application for CER-1236
Cero Therapeutics presents preclinical data on CER-1236
See More Headlines

CERO Stock Analysis - Frequently Asked Questions

CERo Therapeutics' stock was trading at $4.78 at the start of the year. Since then, CERO stock has decreased by 95.4% and is now trading at $0.2181.
View the best growth stocks for 2024 here
.

Shares of CERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that CERo Therapeutics investors own include Verve Therapeutics (VERV), Lithium Americas (LAC), NVIDIA (NVDA), Maxeon Solar Technologies (MAXN), ARM (ARM), AST SpaceMobile (ASTS) and BigBear.ai (BBAI).

Company Calendar

Today
11/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CERO
Previous Symbol
NASDAQ:CERO
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Net Income
$-2,540,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($2.59) per share

Miscellaneous

Free Float
123,253,000
Market Cap
$32.78 million
Optionable
N/A
Beta
-0.50
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NASDAQ:CERO) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners